TFO

[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID

Created:2004-04-21
Last modified:  2021-03-01

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count33
Chiral Atom Count1
Bond Count34
Aromatic Bond Count10
2D diagram of TFO

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle HydrogenToggle Labels

Chemical Component Summary

Name[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID
SynonymsTENOFOVIR
Systematic Name (OpenEye OEToolkits)[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
FormulaC9 H14 N5 O4 P
Molecular Weight287.212
TypeDNA LINKING

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs10.04O=P(O)(O)COC(C)Cn1c2ncnc(c2nc1)N
SMILESCACTVS3.341C[CH](Cn1cnc2c(N)ncnc12)OC[P](O)(O)=O
SMILESOpenEye OEToolkits1.5.0CC(Cn1cnc2c1ncnc2N)OCP(=O)(O)O
Canonical SMILESCACTVS3.341 C[C@H](Cn1cnc2c(N)ncnc12)OC[P](O)(O)=O
Canonical SMILESOpenEye OEToolkits1.5.0 C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(O)O
InChIInChI1.03 InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1
InChIKeyInChI1.03 SGOIRFVFHAKUTI-ZCFIWIBFSA-N

Drug Info: DrugBank

DrugBank IDDB14126 
NameTenofovir
Groups
  • experimental
  • investigational
DescriptionTenofovir is an acyclic nucleotide diester analog of adenosine monophosphate.[A37693] In the most strict sense and due to the fact that it presents a phosphate group bound to the nitrogenous base, it is determined as an actual nucleotide analog.[A37693] The antiviral activities of tenofovir were first reported in 1993 and this agent was commercially available since 2008 in the form of [tenofovir disoproxil] and [tenofovir alafenamide] in order to obtain oral bioavailability.[A18473, A178360]
Synonyms
  • Tenofovir hydrate
  • Tenofovir anhydrous
  • (R)-PMPA
  • Tenofovir (anh.)
  • Tenofovir (anhydrous)
IndicationTenofovir has been shown to be effective against HIV, herpes simplex virus-2, and hepatitis B virus.[A178330] To know more about the specific product indications, please visit the information in the orally available forms of tenofovir, [tenofovir alafenamide] and [tenofovir disoproxil].
Categories
  • Anti-HIV Agents
  • Anti-Infective Agents
  • Anti-Retroviral Agents
  • Antiviral Agents
  • Drugs that are Mainly Renally Excreted
CAS number147127-20-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Reverse transcriptase/RNaseHPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI...unknowninhibitor
Gag-Pol polyproteinMGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGL...unknowninhibitor
Reverse transcriptaseMGVGLSPFLLSQFTSAICSVVRRAFPHCLAFSYMDDVVLGAKTVunknowninhibitor
DNA polymeraseMFCAAGGPASPGGKSAARAASGFFAPHNPRGATQTAPPPCRRQNFYNPHL...unknowninhibitor
Nucleoside diphosphate kinase AMANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKE...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 464205
ChEMBL CHEMBL483
ChEBI CHEBI:63625